Abbott Laboratories Net Income 2006-2018 | ABT
Abbott Laboratories annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Abbott Laboratories net income for the quarter ending September 30, 2018 was $0.563B, a 6.63% decline year-over-year.
- Abbott Laboratories net income for the twelve months ending September 30, 2018 was $886M, a 57.87% decline year-over-year.
- Abbott Laboratories annual net income for 2017 was $0.477B, a 65.93% decline from 2016.
- Abbott Laboratories annual net income for 2016 was $1.4B, a 68.35% decline from 2015.
- Abbott Laboratories annual net income for 2015 was $4.423B, a 93.65% increase from 2014.
| Abbott Laboratories Annual Net Income (Millions of US $) |
|
|---|---|
| 2017 | $477 |
| 2016 | $1,400 |
| 2015 | $4,423 |
| 2014 | $2,284 |
| 2013 | $2,576 |
| 2012 | $5,963 |
| 2011 | $4,728 |
| 2010 | $4,626 |
| 2009 | $5,746 |
| 2008 | $4,881 |
| 2007 | $3,606 |
| 2006 | $1,717 |
| 2005 | $3,372 |
| Abbott Laboratories Quarterly Net Income (Millions of US $) |
|
|---|---|
| Q3 2018 | $563 |
| Q2 2018 | $733 |
| Q1 2018 | $418 |
| Q4 2017 | $-828 |
| Q3 2017 | $603 |
| Q2 2017 | $283 |
| Q1 2017 | $419 |
| Q4 2016 | $798 |
| Q3 2016 | $-329 |
| Q2 2016 | $615 |
| Q1 2016 | $316 |
| Q4 2015 | $767 |
| Q3 2015 | $580 |
| Q2 2015 | $784 |
| Q1 2015 | $2,292 |
| Q4 2014 | $905 |
| Q3 2014 | $538 |
| Q2 2014 | $466 |
| Q1 2014 | $375 |
| Q4 2013 | $590 |
| Q3 2013 | $966 |
| Q2 2013 | $476 |
| Q1 2013 | $544 |
| Q4 2012 | $1,053 |
| Q3 2012 | $1,943 |
| Q2 2012 | $1,725 |
| Q1 2012 | $1,242 |
| Q4 2011 | $1,619 |
| Q3 2011 | $303 |
| Q2 2011 | $1,943 |
| Q1 2011 | $864 |
| Q4 2010 | $1,441 |
| Q3 2010 | $891 |
| Q2 2010 | $1,292 |
| Q1 2010 | $1,003 |
| Q4 2009 | $1,539 |
| Q3 2009 | $1,480 |
| Q2 2009 | $1,288 |
| Q1 2009 | $1,439 |
| Q4 2008 | $1,536 |
| Q3 2008 | $1,085 |
| Q2 2008 | $1,322 |
| Q1 2008 | $938 |
| Q4 2007 | $1,203 |
| Q3 2007 | $717 |
| Q2 2007 | $989 |
| Q1 2007 | $698 |
| Q4 2006 | $-476 |
| Q3 2006 | $716 |
| Q2 2006 | $612 |
| Q1 2006 | $865 |
| Q4 2005 | $976 |
| Q3 2005 | $681 |
| Q2 2005 | $877 |
| Q1 2005 | $838 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $123.892B | $27.390B |
| Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $122.046B | 18.71 |
| Stryker (SYK) | United States | $62.759B | 23.66 |
| Boston Scientific (BSX) | United States | $48.834B | 24.68 |
| Baxter (BAX) | United States | $34.600B | 22.34 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.151B | 15.01 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.845B | 0.00 |
| ResMed (RMD) | United States | $14.616B | 27.87 |
| Perrigo (PRGO) | Ireland | $8.530B | 12.95 |
| Bio-Rad Laboratories (BIO) | United States | $8.041B | 51.42 |
| Canopy Growth (CGC) | Canada | $7.608B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.079B | 19.27 |
| Aurora Cannabis (ACB) | Canada | $5.873B | 32.05 |
| Haemonetics (HAE) | United States | $5.316B | 46.75 |
| ICU Medical (ICUI) | United States | $4.835B | 26.94 |
| Insulet (PODD) | United States | $4.492B | 0.00 |
| Hutchison China MediTech (HCM) | China | $4.108B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.867B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.782B | 0.00 |
| Neogen (NEOG) | United States | $3.211B | 48.63 |
| NuVasive (NUVA) | United States | $3.153B | 29.33 |
| National Vision Holdings (EYE) | United States | $2.871B | 55.54 |
| Quidel (QDEL) | United States | $2.378B | 31.00 |
| Aphria (APHA) | $2.260B | 0.00 | |
| NxStage Medical (NXTM) | United States | $1.935B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.371B | 19.41 |
| AtriCure (ATRC) | United States | $1.182B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $0.999B | 1439.50 |
| VAREX IMAGING (VREX) | United States | $0.974B | 19.57 |
| Meridian Bioscience (VIVO) | United States | $0.833B | 26.55 |
| OraSure Technologies (OSUR) | United States | $0.761B | 42.86 |
| Surmodics (SRDX) | United States | $0.759B | 115.98 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.737B | 23.64 |
| MacroGenics (MGNX) | United States | $0.713B | 0.00 |
| PetIQ (PETQ) | United States | $0.704B | 20.01 |
| Cerus (CERS) | United States | $0.692B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.627B | 19.41 |
| Omeros (OMER) | United States | $0.617B | 0.00 |
| Owens & Minor (OMI) | United States | $0.546B | 6.18 |
| LeMaitre Vascular (LMAT) | United States | $0.537B | 26.39 |
| NanoString Technologies (NSTG) | United States | $0.509B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.499B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.428B | 0.00 |
| Evolus (EOLS) | United States | $0.377B | 0.00 |
| Quanterix (QTRX) | United States | $0.376B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.342B | 22.12 |
| Cytosorbents (CTSO) | United States | $0.316B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.258B | 0.00 |
| Surface Oncology (SURF) | United States | $0.230B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.205B | 0.00 |
| Bovie Medical (BVX) | United States | $0.193B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.186B | 250.75 |
| Chimerix (CMRX) | United States | $0.168B | 0.00 |
| Fonar (FONR) | United States | $0.141B | 7.07 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.136B | 0.00 |
| Imprimis Pharmaceuticals (IMMY) | United States | $0.116B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.108B | 0.00 |
| United-Guardian (UG) | United States | $0.080B | 16.68 |
| Female Health (VERU) | United States | $0.074B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | Israel | $0.072B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.068B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.059B | 18.87 |
| CAS Medical Systems (CASM) | United States | $0.051B | 0.00 |
| Neurotrope (NTRP) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.027B | 0.00 |
| Myomo (MYO) | United States | $0.023B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.022B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.017B | 0.00 |
| Senestech (SNES) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
